Exenatide Treatment in Parkinson's Disease

NCT04305002 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Exenatide
DRUG: Placebo

Sponsor

Center for Neurology, Stockholm

Collaborators

[object Object]